Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.
Conditions: COVID-19; SARS-CoV-2 Infection Interventions: Drug: Molnupiravir Sponsors: Serap Yavuz; MDX Klinik Ara ştırma Egitim ve Danismanlik Ltd. Sti. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Virus and Bronchial Epithelium in Children and the Elderly
Conditions: SARS-CoV-2 Interventions: Biological: SARS-CoV-2; Biological: Adenovirus (AdV); Biological: Rhinovirus; Biological: No Intervention Sponsors: University Hospital, Bordeaux Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Clinical Effects of Sivelestat Sodium on Improving ARDS in Patients With COVID-19
Conditions: ARDS Due to Disease Caused by SARS Co-V-2 Interventions: Drug: Sivelestat sodium; Drug: Control Sponsors: The First Hospital of Jilin University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
Eficacia Ventilatoria y Remolacha
Conditions: SARS CoV 2 Infection; Muscle Disorder; Fatigue Interventions: Dietary Supplement: Remolacha Sponsors: Hospital de Matar ó Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Comparative Study of AnaConDa System Use Versus Conventional Sedation in COVID-19 Patients.
Conditions: SARS CoV 2 Infection; Mechanical Ventilation Complication Interventions: Device: USE OF SEVOFLURANE WITH AnaConDa Sponsors: Hospital Espa ñol de Mexico; Universidad Nacional Autonoma de Mexico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
A Study to Evealuate Safety and Immunogenicity of TI-0010 SARS-CoV-2 Vaccine in Healthy Adults
Conditions: COVID-19; COVID-19 Immunisation Interventions: Biological: TI-0010; Biological: Placebo Sponsors: National Drug Clinical Trial Institute of the Second Affiliated Hospital of Bengbu Medical College; Therorna Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2024 Category: Research Source Type: clinical trials
Phase II, Double Blind, Randomized Trial of CX-4945 in Viral Community Acquired Pneumonia
Conditions: Community-acquired Pneumonia; SARS-CoV-2 -Associated Pneumonia; Influenza With Pneumonia Interventions: Drug: CX-4945 (SARS-CoV-2 domain); Drug: Placebo (SARS-CoV-2 domain); Drug: CX-4945 (Influenza virus domain); Drug: Placebo (Influenza virus domain) Sponsors: Senhwa Biosciences, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data
Conditions: SARS-CoV-2; COVID-19 Vaccines Interventions: Biological: Vaccination Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Consequences in ICU of Vaccination Status of Covid-19 Patients
Conditions: SARS CoV 2 Infection Sponsors: Centre Hospitalier R égional Metz-Thionville Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings
Conditions: SARS-CoV-2 Infection; Influenza A; Influenza B Interventions: Diagnostic Test: Aptitude Medical Systems Metrix COVID/Flu Test Sponsors: Aptitude Medical Systems; Biomedical Advanced Research and Development Authority Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
Consequences in ICU of Vaccination Status of Covid Patients
Conditions: SARS CoV 2 Infection Sponsors: Centre Hospitalier R égional Metz-Thionville Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine
Conditions: SARS-CoV2 Infection Interventions: Biological: PHH-1V81; Biological: Comirnaty Omicron XBB1.5 Sponsors: Hipra Scientific, S.L.U Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
SARS-CoV-2, TESTOSTERONE AND MALE FRAGILITY
Conditions: COVID-19; Testosterone Deficiency; Infertility, Male Interventions: Diagnostic Test: Collection of biological data Sponsors: IRCCS San Raffaele Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials
Clinical Performance Study for EDAN's COVID-19/Flu A/Flu B/RSV Test Kits on Subjects Suspected of Respiratory Infection
Conditions: SARS-CoV2 Infection; Influenza A; Influenza B; Respiratory Syncytial Virus (RSV) Interventions: Device: COVID-19/Flu A/Flu B/RSV Test Kit Sponsors: EDAN Instruments Inc.; MDx CRO (MED IVD HEALTHTECH S.L.) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
A Cohort Study on the Clinical Characteristics and Prognosis of HIV/AIDS Patients Infected With SARS-CoV-2
Conditions: PLWH; Covid-19; Clinical Features; Prognosis Interventions: Other: SARS-CoV-2 Sponsors: The Second Affiliated Hospital of Chongqing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
